CINECA IRIS Institutional Research Information System

CAPRA, ANDREA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 2.357
AS - Asia 1.917
NA - Nord America 1.248
SA - Sud America 329
OC - Oceania 92
AF - Africa 67
Totale 6.010
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.011
CN - Cina 805
IT - Italia 769
JP - Giappone 366
ES - Italia 303
GB - Regno Unito 250
DE - Germania 202
IN - India 202
BR - Brasile 146
MX - Messico 132
FR - Francia 111
SG - Singapore 110
TR - Turchia 109
HK - Hong Kong 105
CA - Canada 97
RU - Federazione Russa 77
NL - Olanda 75
AU - Australia 73
IE - Irlanda 72
CO - Colombia 63
SE - Svezia 60
GR - Grecia 53
CH - Svizzera 52
PL - Polonia 49
AT - Austria 41
FI - Finlandia 36
VN - Vietnam 36
BE - Belgio 35
PT - Portogallo 34
AR - Argentina 31
TW - Taiwan 28
CL - Cile 26
ID - Indonesia 25
KR - Corea 24
MA - Marocco 23
DK - Danimarca 21
NZ - Nuova Zelanda 19
PE - Perù 18
TH - Thailandia 18
CZ - Repubblica Ceca 17
NO - Norvegia 17
EG - Egitto 16
IL - Israele 16
BO - Bolivia 14
RS - Serbia 13
EC - Ecuador 12
HU - Ungheria 12
SA - Arabia Saudita 11
VE - Venezuela 11
HR - Croazia 10
KZ - Kazakistan 10
MK - Macedonia 10
TN - Tunisia 10
JO - Giordania 9
UA - Ucraina 9
UY - Uruguay 8
ZA - Sudafrica 8
IR - Iran 7
BA - Bosnia-Erzegovina 6
PH - Filippine 6
SI - Slovenia 6
BG - Bulgaria 5
RO - Romania 5
AE - Emirati Arabi Uniti 4
CR - Costa Rica 4
MM - Myanmar 4
AM - Armenia 3
BD - Bangladesh 3
GT - Guatemala 3
SN - Senegal 3
UZ - Uzbekistan 3
AL - Albania 2
CY - Cipro 2
EE - Estonia 2
GE - Georgia 2
IQ - Iraq 2
LT - Lituania 2
LY - Libia 2
MY - Malesia 2
NG - Nigeria 2
PS - Palestinian Territory 2
CD - Congo 1
CI - Costa d'Avorio 1
CU - Cuba 1
LB - Libano 1
PK - Pakistan 1
QA - Qatar 1
RE - Reunion 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 6.010
Salva come PNG Salva come JPEG
Città #
Beijing 111
Florence 95
Shanghai 91
Madrid 79
Tokyo 70
London 67
Dublin 66
Singapore 65
Bologna 58
Chandler 55
Rome 54
Turin 54
Milan 52
São Paulo 51
Barcelona 45
Central 45
Istanbul 42
Guangzhou 39
Frankfurt am Main 36
Santa Clara 36
Moscow 35
Paris 33
Bogotá 32
Torino 32
Los Angeles 31
Chengdu 30
Chicago 30
Hangzhou 30
New York 30
Sydney 30
Mumbai 29
Helsinki 27
Vienna 27
Mexico City 26
Nyköping 26
Toronto 26
Nanjing 25
Athens 24
Bari 23
Ashburn 22
Hyderabad 21
Manchester 21
Hong Kong 20
Tianjin 20
Catania 19
Ludhiana 19
Melbourne 19
Salamanca 19
Auckland 18
Buenos Aires 18
Chongqing 18
Houston 18
Padova 18
Seattle 18
Berlin 17
Changsha 17
Delhi 17
Munich 17
Yokohama 17
Ankara 16
Fairfield 16
Jakarta 16
Loma Linda 16
Montreal 16
Atlanta 15
Chennai 15
Lisbon 15
Zurich 15
Dallas 14
Lima 14
Rio de Janeiro 14
Thessaloniki 14
Valencia 14
Bangkok 13
Pittsburgh 13
Cambridge 12
Little Rock 12
Medford 12
New Delhi 12
Palermo 12
Pune 12
Salvador 12
Boston 11
Breda 11
Guadalajara 11
Princeton 11
Taipei 11
Waynesboro 11
Wuhan 11
Xi'an 11
Amsterdam 10
Birmingham 10
Columbus 10
Curitiba 10
Hanoi 10
Hefei 10
Santa Cruz 10
Santander 10
Shenyang 10
St Petersburg 10
Totale 2.638
Salva come PNG Salva come JPEG
Nome #
Second Revision of the International Staging System (R2-ISS) for Overall Survival in Multiple Myeloma: A European Myeloma Network (EMN) Report Within the HARMONY Project 3.300
Carfilzomib with cyclophosphamide and dexamethasone or lenalidomide and dexamethasone plus autologous transplantation or carfilzomib plus lenalidomide and dexamethasone, followed by maintenance with carfilzomib plus lenalidomide or lenalidomide alone for patients with newly diagnosed multiple myeloma (FORTE): a randomised, open-label, phase 2 trial 1.839
Development and Validation of a Simplified Score to Predict Early Relapse in Newly Diagnosed Multiple Myeloma in a Pooled Dataset of 2,190 Patients 151
Minimal residual disease assessment by multiparameter flow cytometry in transplant-eligible myeloma in the EMN02/HOVON 95 MM trial 147
Carfilzomib, cyclophosphamide and dexamethasone for newly diagnosed, high-risk myeloma patients not eligible for transplant: a pooled analysis of two studies 143
Early Relapse Risk in Patients with Newly Diagnosed Multiple Myeloma Characterized by Next-generation Sequencing 130
Dose/schedule-adjusted Rd-R vs continuous Rd for elderly, intermediate-fit patients with newly diagnosed multiple myeloma 110
Octogenarian newly diagnosed multiple myeloma patients without geriatric impairments: the role of age >80 in the IMWG frailty score 93
Bortezomib-dexamethasone as maintenance therapy or early retreatment at biochemical relapse versus observation in relapsed/refractory multiple myeloma patients: a randomized phase II study 73
Ixazomib-based induction regimens plus ixazomib maintenance in transplant-ineligible, newly diagnosed multiple myeloma: the phase II, multi-arm, randomized UNITO-EMN10 trial 62
Carfilzomib induction, consolidation, and maintenance with or without autologous stem-cell transplantation in patients with newly diagnosed multiple myeloma: pre-planned cytogenetic subgroup analysis of the randomised, phase 2 FORTE trial 37
Totale 6.085
Salva come PNG Salva come JPEG
Categoria #
all - tutte 10.836
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.836
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202022 0 0 0 0 0 0 0 0 14 2 1 5
2020/2021114 2 7 8 8 3 5 12 10 6 3 7 43
2021/2022319 18 11 7 20 22 14 20 26 20 32 45 84
2022/20231.843 22 31 56 158 156 174 169 194 227 164 234 258
2023/20242.782 234 260 212 240 236 233 235 242 97 229 305 259
2024/20251.005 161 184 190 193 277 0 0 0 0 0 0 0
Totale 6.085